期刊文献+

原发韦氏环黏膜相关淋巴组织淋巴瘤的临床特点和长期治疗结果 被引量:3

Primary mucosa-associated lymphoid tissue lymphoma of Waldeyer's ring: clinical characteristics andlong-term outcome
原文传递
导出
摘要 目的分析原发韦氏环黏膜相关淋巴组织(MALT)淋巴瘤的临床特点和长期治疗结果。方法回顾分析本院初治的10例原发韦氏环MALT淋巴瘤,其中男1例、女9例,Iε期7例、ⅡE期3例。单纯放疗3例,7例在放疗前加1-4周期化疗或再加辅助化疗。放疗中位剂量40Gy,化疗方案以CHOP方案为主。结果中位年龄58岁,均无全身症状,只有1例乳酸脱氢酶升高。疗后完全缓解率100%。中位随访90个月,全组5年总生存率、疾病相关生存率和无进展生存率分别为90%、100%和80%。1例死于直肠癌肝转移,1例脑部复发经放疗挽救治愈。结论韦氏环MALT淋巴瘤与其他胃外MALT淋巴瘤有类似临床特点,放疗为主的治疗取得了出色的长期疗效。 Objective To investigate the clinical characteristics and long-term outcome of patients with mucosa-associated lymphoid tissue (MALT) lymphoma of Waldeyer's ring. Methods Ten patients were retrospectively analyzed. Seven patients had stage It and 3 patients had stage IIE disease. All patients received radiation therapy with a median dose of 40 Gy, and 7 patients also received 1 to 4 cycles of CHOP- based chemotherapy before radiation. Results The ratio of male to female was 1 : 9. The median age was 58 years. No patient had B symptoms. One patient had elevated LDH level. The complete response rate after treatment was 100%. With median follow-up periods of 90 months, 1 patient died from rectal cancer. One patient developed brain metastasis and was salvaged by radiotherapy. The 5-year overall survival, cancer specific survival and progression-free survival rates were 90% , 100% and 80% , respectively. Conclusions The clinical characteristics of Waldeyer's ring MALT lymphoma were similar to that of nongastric MALT lymphoma. For patients with Waldeyer's ring MALT lymphoma, primary radiotherapy can result in excellent long-term survival.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2012年第2期149-151,共3页 Chinese Journal of Radiation Oncology
关键词 原发韦氏环 黏膜相关淋巴组织 淋巴瘤 临床特点 治疗 Lymphoma / radiotherapy Lymphoma , mucosa - associated lymphoid tissue Lymphoma, Waldeyer's ring Prognosis
  • 相关文献

参考文献22

  • 1Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol, 1999,36 : 139-147.
  • 2Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood,2000,95:802-806.
  • 3. Raderer M, Streubel B, Woehrer S, et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res ,2005,11:3349-3352.
  • 4Raderer M, Whrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa- associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol,2006,24:3136-3141.
  • 5Arcaini L, Burcheri S, Rossi A, et al. Nongastric marginal-zone B-cell MALT lymphoma:prognostic value of disease dissemination. Oncologist ,2006,11:285-291.
  • 6李百周,陆洪芬,周晓燕,杨文涛,孔蕴毅,范月珍,施达仁.不同部位黏膜相关淋巴组织结外边缘区B细胞淋巴瘤中染色体的异常及其意义[J].中华病理学杂志,2008,37(9):604-608. 被引量:3
  • 7Li YX, Fang H, Liu QF, et al. outcome of nasal-type NK/T-cell Blood ,2008,112:3057-3064.
  • 8Clinical features and treatment lymphoma of Waldeyer ring. Qi SN, Li YX, Wang H, et al. Diffuse large B-cell lymphoma: clinical characterization and prognosis of Waldeyer ring versus lymph node presentation. Cancer,2009,115:4980-4989.
  • 9Panlsen J, Lennert K. Low-grade B-cell lymphoma of mucosa- associated lymphoid tissue type in Waldeyer' s ring. Histopathology, 1994,24 : 1-11.
  • 10Cheson BD, Homing SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non- Hodgkin's lymphomas. J Clin Oncol, 1999,17 : 1244-1253.

二级参考文献36

  • 1杨文秀,李甘地,周桥,刘卫平,陈铌,李雷.API2-MALT1融合基因表达与结外弥漫大B细胞淋巴瘤临床病理特征与预后的关系[J].贵州医药,2005,29(4):291-294. 被引量:4
  • 2杨文秀,李甘地,周桥,刘卫平,李雷,陈铌.结外B细胞淋巴瘤组织中API2-MALT1融合基因的检测及其意义[J].中华病理学杂志,2006,35(2):92-96. 被引量:7
  • 3Ott G, Katzenberger T, Greiner A, et al. The t ( 11; 18 ) (q21;q21) chromosometranslocation is a frequent and specific aberration in low-grade but not high-grade malignant non- Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res, 1997, 57 ( 18 ) :3944-3948.
  • 4Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B- cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood, 2002, 99(1) :3-9.
  • 5Streubel B, Simonitsch-Klupp I, MOllauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia, 2004, 18 (10) : 1722-1726.
  • 6Ye H, Gong L, Liu H, et al. MALT lymphoma with t(14;18) (q32; q21 )/IgH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression. J Pathol, 2005, 205 (3) : 293- 301.
  • 7Inagaki H, Nakamura T, Li C, et al. Gastric MALT lymphomas are divided into three groups based on responsiveness to Helicobacter Pylori eradication and detection of API2-MALT1 fusion. Am J Surg Pathol, 2004, 28(12) :1560-1567.
  • 8Willis TG, Jadayel DM, Du MQ, et al. BCL10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell, 1999, 96( 1 ) :35..45.
  • 9Macintyre E, Willerford D, Morris SW. Non-Hodgkin' s lymphoma : molecular features of B cell lymphoma. Hematology Am Soc Hematol Educ Program, 2000:180-204.
  • 10Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18) (q32; q21 ) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood, 2003, 101 (6) : 2334- 2339.

共引文献4

同被引文献22

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部